Skip to main content
. 2004 May 17;199(10):1421–1431. doi: 10.1084/jem.20040191

Figure 5.

Figure 5.

CTL recognition of endogenously processed EBNA1 epitopes. (A) HLA B35+ and HLA B35 LCLs were used as targets in a standard 51Cr-release assay to assess endogenous processing of EBNA1. (A) A CTL clone specific for the HLA B35-binding HPVGEADYFEY epitope was added to target cells at the E/T ratios indicated. (B) An HLA B35+ LCL, 721.221 LCLs, 721.221 LCLs transfected with HLA B*3501, T2 LCLs, and T2 LCLs transfected with HLA B*3501 were used as targets in a standard 51Cr-release assay to assess CTL activity to an HPVGEADYFEY-specific CTL clone at an E/T ratio of 5:1. These data are a representation of three separate experiments.